Table 4.
Distribution of elderly patients with oral and maxillofacial lesions according to age groups, sex, and histopathological type of malignant lesions
| Age groups [n (%)] (years) | Sex [n (%)] | ||||
|---|---|---|---|---|---|
| The histological type of malignant lesion (N=272) | 60–74 | 75+ | Female | Male | Total [n (%)] |
| Carcinoma (N=255, 93.7%) | |||||
| Adenocarcinoma | 9 (75.0) | 3 (25.0) | 6 (50.0) | 6 (50.0) | 12 (100.0) |
| Adenoid cystic carcinoma | 12 (63.2) | 7 (36.8) | 7 (36.8) | 12 (63.2) | 19 (100.0) |
| Basal cell carcinoma | 1 (50.0) | 1 (50.0) | 1 (50.0) | 1 (50.0) | 2 (100.0) |
| Metastatic carcinoma | 2 (66.7) | 1 (33.3) | 3 (100.0) | – | 3 (100.0) |
| Mucoepidermoid carcinoma | 2 (40.0) | 3 (60.0) | 2 (40.0) | 3 (60.0) | 5 (100.0) |
| Squamous cell carcinoma | 155 (73.8) | 55 (26.2) | 102 (48.6) | 108 (51.4) | 210 (100.0) |
| Secretory carcinoma | 1 (100.0) | – | 1 (100.0) | – | 1 (100.0) |
| Verrucous carcinoma | 1 (33.3) | 2 (66.7) | 1 (33.3) | 2 (66.7) | 3 (100.0) |
| Lymphoma (N=7, 2.6%) | |||||
| Hodgkin’s lymphoma | 2 (100.0) | – | – | 2 (100.0) | 2 (100.0) |
| Non-Hodgkin’s lymphoma | 3 (60.0) | 2 (40.0) | 1 (20.0) | 4 (80.0) | 5 (100.0) |
| Sarcoma (N=3, 1.1%) | |||||
| Fibrosarcoma | – | 1 (100.0) | 1 (100.0) | – | 1 (100.0) |
| Leiomyosarcoma | 1 (100.0) | – | – | 1 (100.0) | 1 (100.0) |
| Osteosarcoma | 1 (100.0) | – | 1 (100.0) | – | 1 (100.0) |
| Other (N=7, 2.6%) | |||||
| Kaposi’s sarcoma | – | 1 (100.0) | – | 1 (100.0) | 1 (100.0) |
| Malignant melanoma | 1 (33.3) | 2 (66.7) | 2 (66.7) | 1 (33.3) | 3 (100.0) |
| Plasmacytoma | 2 (66.7) | 1 (33.3) | 2 (66.7) | 1 (33.3) | 3 (100.0) |